I. M. Adcock (London, United Kingdom), L. Nielsen (Aarhus, Denmark)
New synthetic compound cyclohexylmethoxy derivative inhibits asthmatic reaction in mouse model
M. K. Kim, Y. Kim, J. C. Ryu, S. H. Jung, S. H. Lee (Cheongjoo, Seoul, Daejeon, Daegoo, Republic Of Korea)
|  |
In vitro effect of shRNA plasmid targeting murine IL-5Rα on IL-5 induced bone marrow eosinopoiesis
H. Mao, K. Yin (Nanjing, China)
| |
Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4-induced contractions of isolated human bronchi
T. Nabe, M. Fujita, Y. Yonetomi, T. Nakao, M. Fujii, K. Kawabata, K. Kishikawa, M. Horiba, S. Kohno (Kyoto, Osaka, Ogaki, Japan)
| |
Prostanoid DP1 receptor as a target for respiratory diseases
K. Metters, G. O‘Neill, T. R. Jones (Dorval, Canada)
| |
Anti-eosinophilic activity of simendans
H. Kankaanranta, X. Zhang, E. Nissinen, M. Ruotsalainen, H. Haikala, E. Moilanen (Tampere, Espoo, Finland)
| |
The PDE4-inhibitors roflumilast and rolipram modulate fibroblast collagen-gel contraction and chemotaxis mediated by autocrine PGE2 synthesis induced by TGF-β1
S. Togo, X. Liu, T. Kobayashi, R. Ertl, H. Sugiura, L. Shen, S. I. Rennard (Omaha, United States Of America)
| |
Effects of roflumilast on early and late allergic response and airway hyperresponsiveness in Aspergillus fumigatus-sensitized mice
H. G. Hoymann, R. Korolewitz, A. Braun, N. Krug, L. Wollin, R. Beume (Hannover, Konstanz, Germany)
| |
Pharmacological induction of HDAC activity restores steroid function in macrophages subjected to oxidative stress
P. Kirkham, K. Meja, J. Marwick (Horsham, United Kingdom)
| |
Curcumin restores glucocorticoid function and inhibits cigarette smoke-mediated IL-8 release in oxidant stressed monocytic U937 cells
P. Kirkham, K. Meja, M. Bauter, I. Rahman (Horsham, United Kingdom; Rochester, United States Of America)
| |
Effects of exogenous uridine in a sephadex-induced lung inflammation model in rats
C. Evaldsson-Gautam, I. Rydén, S. Uppugunduri (Linköping, Sweden)
| |
Plasma concentrations of four corticosteroids following inhalation
K. Mortimer, T. W. Harrison, Y. Tang, K. Wu, S. Sahasranaman, G. Hochhaus, A. E. Tattersfield (Nottingham, United Kingdom; Gainesville, United States Of America)
| |
Carmoterol, a new long-acting β2-agonist, positively interacts with M3-muscarinic antagonist
R. Razzetti, M. Civelli, F. Berti, G. Rossoni (Parma, Milan, Italy)
| |
Positive interaction of carmoterol, a new long-acting β2-agonist, with budesonide
R. Razzetti, F. Pastore, M. Civelli, G. Rossoni (Parma, Milan, Italy)
| |
Pharmacological characterization of indacaterol, a novel 24-hour β2-agonist, on isolated human bronchus
E. Naline, M. Molimard, R. Fairhurst, A. Trifilieff, C. Advenier (Paris, Bordeaux, France; Horsham, United Kingdom)
| |
Duration and onset of action of indacaterol, a novel 24-hour β2-agonist, on isolated human bronchus
E. Naline, M. Molimard, R. Fairhurst, A. Trifilieff, C. Advenier (Paris, Bordeaux, France; Horsham, United Kingdom)
| |
Once-daily administration of indacaterol does not induce tachyphylaxis in vivo
C. H. Battram, J. Mok, C. A. Lewis (Horsham, United Kingdom)
| |
Indacaterol: preclinical evidence for an improved safety profile vs LABAs
C. A. Lewis, L. Jordan, D. C. Farr, J. Fozard (Horsham, United Kingdom; Basel, Switzerland)
| |
Glycopyrrolate exerts medium-duration bronchodilator activity in guinea-pig and human airways
G. Villetti, M. Bergamaschi, F. Bassani, P. T. Bolzoni, S. Harrison, P. M. Gigli, A. Ianni, M. Civelli, P. Geppetti, R. Patacchini (Parma, Florence, Italy)
| |
Potency and duration of action of R,R-glycopyrrolate (RRG) on acetylcholine (ACh) induced bronchoconstriction as compared to tiotropium (TIO) in unrestrained conscious mice
P. J. Cnota, A. Ray, J. Maus (Bad Homburg, Germany; Gurgaon, India)
| |
Synergistic action of the anticholinergic r,r-glycopyrrolate with glucocorticoids and PDE4-inhibitors
A. Pahl, J. Maus, P. Cnota, U. Petzold, I. Szelenyi (Erlangen, Bad Homburg, Germany)
| |